These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22910132

  • 1. Evaluating and assessing dabigatran drug interactions.
    Nguyen T, Wong E.
    Consult Pharm; 2012 Jul; 27(7):509-12. PubMed ID: 22910132
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD, Bona R, Baker WL.
    Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 4. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L, Sherman O.
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [Abstract] [Full Text] [Related]

  • 5. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A, Bailey C, Abdelhafiz AH.
    Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
    [Abstract] [Full Text] [Related]

  • 6. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C, Robertson C, Shivakumar S, Lee M.
    J Can Dent Assoc; 2013 Sep; 79():d74. PubMed ID: 23920075
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced exanthem following dabigatran.
    Whitehead H, Boyd JM, Blais DM, Hummel J.
    Ann Pharmacother; 2011 Oct; 45(10):e53. PubMed ID: 21881034
    [Abstract] [Full Text] [Related]

  • 8. Warfarin versus dabigatran: comparing the old with the new.
    Abraham ME, Marcy TR.
    Consult Pharm; 2012 Feb; 27(2):121-4. PubMed ID: 22330953
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [Abstract] [Full Text] [Related]

  • 10. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 12. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J, Kottalgi M, Cirra VR, Shah N, Kamboj R.
    Am J Ther; 2012 Nov; 19(6):e182-5. PubMed ID: 23154229
    [Abstract] [Full Text] [Related]

  • 13. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.
    Circulation; 2012 Feb 07; 125(5):669-76. PubMed ID: 22215856
    [Abstract] [Full Text] [Related]

  • 14. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C, Rakusan S, Wimpissinger FT, Finsterer J.
    Thromb Haemost; 2012 Sep 07; 108(3):579-81. PubMed ID: 22739630
    [No Abstract] [Full Text] [Related]

  • 15. [Direct oral thrombin inhibitor, "dabigatran"].
    Yasaka M.
    Nihon Rinsho; 2013 Jan 07; 71(1):113-8. PubMed ID: 23631181
    [Abstract] [Full Text] [Related]

  • 16. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C, Barrios V, Jimenez D.
    Cardiovasc Ther; 2010 Oct 07; 28(5):295-301. PubMed ID: 20718760
    [Abstract] [Full Text] [Related]

  • 17. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C, George J, Levine R.
    N Z Med J; 2013 Mar 01; 126(1370):110-2. PubMed ID: 23474519
    [Abstract] [Full Text] [Related]

  • 18. Interpretation of point-of-care INR results in patients treated with dabigatran.
    van Ryn J, Baruch L, Clemens A.
    Am J Med; 2012 Apr 01; 125(4):417-20. PubMed ID: 22306274
    [Abstract] [Full Text] [Related]

  • 19. Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
    Hughes PJ, Freeman MK.
    Consult Pharm; 2012 Jun 01; 27(6):445-52. PubMed ID: 22698551
    [Abstract] [Full Text] [Related]

  • 20. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L, Ringwald J, Schwab S, Köhrmann M.
    N Engl J Med; 2013 Jun 20; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.